Apricus Biosciences, Inc.
) was a big mover last session, as the company saw its shares rise
almost 19% on the day. The move came on solid volume too with far
more shares changing hands than in a normal session. This reverses
the recent trend for the company, as the stock is now down more
than 9% in the past one-month time frame.
The company has seen one positive and one negative estimate
revision in the past 30 days, while its Zacks Consensus Estimate
moved lower over the same time frame, suggesting trouble down the
road. So make sure to keep an eye on this stock going forward to
see if this recent move higher can last.
Apricus Biosciences currently has a Zacks Rank #3 (Hold) while its
Some better-ranked medical stocks include
Enanta Pharmaceuticals, Inc.
). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
APPRICUS BIOSCI (APRI): Free Stock Analysis
ENANTA PHARMA (ENTA): Free Stock Analysis
GRIFOLS SA-ADR (GRFS): Free Stock Analysis
IMMUNOGEN INC (IMGN): Free Stock Analysis
To read this article on Zacks.com click here.